We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Smallpox Vaccine Effective for Monkeypox

By Biotechdaily staff writers
Posted on 23 Aug 2005
Researchers using a sensitive immunoassay to study the 2003 outbreak of monkeypox in the United States have found that while 72 cases had been reported, the actual number of individuals who contracted the disease was probably much greater, since those who had been vaccinated against smallpox did not develop symptoms of monkeypox.

Investigators at the Oregon Health & Science University (Beaverton, OR, USA) tested sera from individuals exposed to monkeypox during the 2003 Wisconsin outbreak. More...
Those who had contracted the disease, whether or not they became ill, were detected with a highly accurate enzyme-linked immunosorbent assay (ELISA) that demonstrated 95% sensitivity and 90% specificity.

Results published in the August 7, 2005, online edition of Nature Medicine indicated that the 2003 monkeypox outbreak probably extended beyond the officially recognized 72 cases. This conclusion was based on the identification of three previously unreported cases of monkeypox in individuals at 13, 29, and 48 years after smallpox vaccination. These individuals were unaware that they had been infected because they did not experience any recognizable disease symptoms.

"Our research demonstrates that the limitations of currently used technology likely allowed monkeypox cases to slip through the system. This problem was further exacerbated by the two-week delay that occurred during the diagnosis of the first monkeypox cases,” explained senior author Dr. Mark Slifka, assistant professor of molecular microbiology and immunology at Oregon Health & Science University. "If the 2003 outbreak had been smallpox instead of monkeypox, the situation could have been much worse because secondary spread of the virus to other victims would likely have occurred before the outbreak was recognized.”



Related Links:
Oregon Health & Science Univ

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.